FDA Inspection
The Ritedose CorporationThe Ritedose Corporation – FDA Inspection, Apr 18, 2019
Record Details
This FDA Inspection record concerns The Ritedose Corporation, with an inspection on April 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2eb6871a-e581-45f6-a645-8912fc5af088
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1089541
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of The Ritedose Corporation
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2025 | VAI | Atlanta District Office | Drug Quality Assurance |
| March 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 16, 2018 | Not classified | Atlanta District Office | |
| March 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 31, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for The Ritedose Corporation
- FDA Inspection 1250871 - 2025-02-28
- FDA Inspection 1165123 - 2022-03-22
- FDA Inspection 1045279 - 2018-02-16
- FDA Inspection 1015894 - 2017-03-03
- FDA Inspection 940802 - 2015-07-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.